BRPI0810665A2 - Processo para a preparação de intermediário de inibidor da protease de hcv - Google Patents

Processo para a preparação de intermediário de inibidor da protease de hcv

Info

Publication number
BRPI0810665A2
BRPI0810665A2 BRPI0810665-7A2A BRPI0810665A BRPI0810665A2 BR PI0810665 A2 BRPI0810665 A2 BR PI0810665A2 BR PI0810665 A BRPI0810665 A BR PI0810665A BR PI0810665 A2 BRPI0810665 A2 BR PI0810665A2
Authority
BR
Brazil
Prior art keywords
hcv protease
protease inhibitor
inhibitor intermediate
tripeptides
macrocyclic
Prior art date
Application number
BRPI0810665-7A2A
Other languages
English (en)
Inventor
Francois Gantz
Helmut Stahr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0810665A2 publication Critical patent/BRPI0810665A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BRPI0810665-7A2A 2007-04-24 2008-04-15 Processo para a preparação de intermediário de inibidor da protease de hcv BRPI0810665A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07106771 2007-04-24
PCT/EP2008/054518 WO2008128921A1 (en) 2007-04-24 2008-04-15 Process for hcv protease inhibitor intermediate

Publications (1)

Publication Number Publication Date
BRPI0810665A2 true BRPI0810665A2 (pt) 2014-11-04

Family

ID=39564613

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810665-7A2A BRPI0810665A2 (pt) 2007-04-24 2008-04-15 Processo para a preparação de intermediário de inibidor da protease de hcv

Country Status (14)

Country Link
US (1) US7847106B2 (pt)
EP (1) EP2150548B1 (pt)
JP (1) JP5390510B2 (pt)
KR (1) KR101467598B1 (pt)
CN (1) CN101663294A (pt)
AT (1) ATE490961T1 (pt)
AU (1) AU2008240834B2 (pt)
BR (1) BRPI0810665A2 (pt)
CA (1) CA2684086C (pt)
DE (1) DE602008003922D1 (pt)
ES (1) ES2355437T3 (pt)
IL (1) IL201299A (pt)
MX (1) MX2009011370A (pt)
WO (1) WO2008128921A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
RU2008152171A (ru) 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
AP2009005057A0 (en) 2007-05-10 2009-12-31 Array Biopharma Inc Novel peptide inhibitors of hepatitis c virus replication
AR070413A1 (es) 2008-02-04 2010-04-07 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de proteasa de serina
AP2010005416A0 (en) 2008-04-15 2010-10-31 Intermune Inc Novel macrocyclic inhibitors of hepatitis c virus replication.
WO2009147537A2 (en) 2008-05-27 2009-12-10 Dako Denmark A/S Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
US8207341B2 (en) 2008-09-04 2012-06-26 Bristol-Myers Squibb Company Process or synthesizing substituted isoquinolines
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
US9303287B2 (en) * 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
TW201040181A (en) 2009-04-08 2010-11-16 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
US8232246B2 (en) 2009-06-30 2012-07-31 Abbott Laboratories Anti-viral compounds
JP2012532146A (ja) * 2009-07-02 2012-12-13 ドクター・レディーズ・ラボラトリーズ・リミテッド アミノビニルシクロプロパンカルボン酸誘導体の分割のための酵素および方法
AR077712A1 (es) 2009-08-05 2011-09-14 Idenix Pharmaceuticals Inc Inhibidores de serina proteasa macrociclica
PE20140039A1 (es) 2010-12-30 2014-03-01 Enanta Pharm Inc Inhibidores de serina proteasa de hepatitis c a base de macrociclicos de fenantridina
CA2822556A1 (en) 2010-12-30 2012-07-05 Enanta Pharmaceuticals, Inc Macrocyclic hepatitis c serine protease inhibitors
TW201309690A (zh) 2011-02-10 2013-03-01 Idenix Pharmaceuticals Inc 巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
US8957203B2 (en) 2011-05-05 2015-02-17 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US8691757B2 (en) 2011-06-15 2014-04-08 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2013046033A1 (en) 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
US11118226B2 (en) 2011-10-21 2021-09-14 Agilent Technologies, Inc. Hybridization compositions and methods
US20140100364A1 (en) 2012-10-08 2014-04-10 Abbvie Inc. Compounds Useful For Making HCV Protease Inhibitors
MA37992B1 (fr) 2012-10-19 2018-09-28 Bristol Myers Squibb Co Composes inhibiteurs de protéase ns3 pour une utilisation dans le traitement de l’infection par le virus de l'hépatite c.
EP2914613B1 (en) 2012-11-02 2017-11-22 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
US9334279B2 (en) 2012-11-02 2016-05-10 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US9643999B2 (en) 2012-11-02 2017-05-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
EP2914614B1 (en) 2012-11-05 2017-08-16 Bristol-Myers Squibb Company Hepatitis c virus inhibitors
US9580463B2 (en) 2013-03-07 2017-02-28 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
CN109678787A (zh) * 2018-12-31 2019-04-26 南京晓庄学院 一种新的hcv病毒ns3/4a抑制剂合成中间体及合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283293A (en) * 1990-12-14 1994-02-01 Corvas, Inc. Reagents for automated synthesis of peptide analogs
AR045047A1 (es) * 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2540858C (en) * 2003-10-14 2009-12-08 Intermune, Inc. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
TWI387603B (zh) * 2005-07-20 2013-03-01 Merck Sharp & Dohme Ｈｃｖ ｎｓ３蛋白酶抑制劑
GB0517279D0 (en) * 2005-08-23 2005-10-05 Amura Therapeutics Ltd Biologically active compounds
RU2008152171A (ru) * 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
US7582605B2 (en) * 2006-08-11 2009-09-01 Enanta Pharmaceuticals, Inc. Phosphorus-containing hepatitis C serine protease inhibitors

Also Published As

Publication number Publication date
DE602008003922D1 (de) 2011-01-20
WO2008128921A1 (en) 2008-10-30
IL201299A (en) 2013-11-28
JP5390510B2 (ja) 2014-01-15
EP2150548B1 (en) 2010-12-08
ES2355437T3 (es) 2011-03-25
CA2684086C (en) 2014-05-27
IL201299A0 (en) 2010-05-31
KR20100015710A (ko) 2010-02-12
AU2008240834A1 (en) 2008-10-30
CN101663294A (zh) 2010-03-03
EP2150548A1 (en) 2010-02-10
AU2008240834B2 (en) 2012-08-23
US7847106B2 (en) 2010-12-07
MX2009011370A (es) 2009-11-05
JP2010525007A (ja) 2010-07-22
ATE490961T1 (de) 2010-12-15
KR101467598B1 (ko) 2014-12-01
CA2684086A1 (en) 2008-10-30
US20080269502A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
BRPI0810665A2 (pt) Processo para a preparação de intermediário de inibidor da protease de hcv
MX2010006659A (es) Proceso para la preparacion de un macrociclo.
MX2009008271A (es) Procesos e intermediarios para la preparacion de un inhibidor de proteasa macrocilico del vhc.
CR10662A (es) Compuestos de metilpiridopirimidinona
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
CY1112221T1 (el) S-τριαζολυλ αλφα-μερκαπτοακετανιλιδες ως αναστολεις της αντιστροφης μεταγραφασης του ηιv
ATE542798T1 (de) Organische verbindungen
CR20110286A (es) Proceso para la preparacion de derivados de l-alanina protegidos
ECSP11010889A (es) INHIBIDORES DE cMET
CY1109766T1 (el) Παραγωγα αζαπεπτιδιου ως αναστολεις πρωτεασης hiv
SG171593A1 (en) Inhibitors of c-fms kinase
ECSP10010271A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
MX2009009174A (es) Inhibidores de serina-proteasas para el tratamiento de infecciones por el virus de hepatitis c.
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
EA200900946A1 (ru) Новый способ синтеза агомелатина
CU20090009A7 (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
TNSN08244A1 (en) Process for the preparation of ferri-succinylcasein
EA200870038A1 (ru) Способ получения аминов
BRPI0508430A (pt) processo para a preparação de inibidores da triptase
GT201000298A (es) 2,6-diamino-pirimidin-z-il-carboxamidas como inhibidores de syk o jak quinasas
EA200900943A1 (ru) Новый способ синтеза агомелатина
BRPI0410157A (pt) bioisostéreos de actinonina
BRPI0406893A (pt) Derivados de acilaminotiazol, a respectiva preparação e a respectiva utilização como inibidores da produção do peptìdeo betaamilóide
BRPI0611954A2 (pt) processos para a produÇço de compostos de anel fundido policÍclico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]